Screener
USANA Health Sciences USNA EBITDA
Discontinued — last reported Q1 '26
EBITDA at other companies
Other financials
Where this comes from
Calculated from USANA Health Sciences’s reported figures.
The source filing: USANA Health Sciences’s 10-Q, filed May 12, 2026. Open the filing →
- Filed
- May 12, 2026, 4:35 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0000896264-26-000034
FAQ
- What is USANA Health Sciences's EBITDA?
- USANA Health Sciences (USNA) reported EBITDA of $22.15M in Q1 2026.
- How has USANA Health Sciences's EBITDA changed year-over-year?
- USANA Health Sciences's EBITDA decreased by 7.7% year-over-year, from $24.01M to $22.15M.
- What is the long-term trend for USANA Health Sciences's EBITDA?
- Over 3 years (2022 to 2025), USANA Health Sciences's EBITDA has grown at a -16.7% compound annual growth rate (CAGR), from $121.01M to $69.99M.
- What does EBITDA mean?
- Earnings before interest, taxes, depreciation, and amortization — EBIT plus the D&A add-back from the cash-flow statement (EBITDA = EBIT + D&A). A proxy for cash earnings that strips out financing, tax, and non-cash charges.
Ask your AI about USANA Health Sciences's ebitda.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude